Plasma Fas Ligand, an Inducer of Apoptosis, and Plasma Soluble Fas, an Inhibitor of Apoptosis, in Patients With Chronic Congestive Heart Failure
Authors:
- Shinya MinatoguchiSMShinya Minatoguchi
- Mitsuru SeishimaMSMitsuru Seishima
- Kiyoji AsanoKAKiyoji Asano
- Toshiyuki NodaTNToshiyuki Noda
- Norio YasudaNYNorio Yasuda
- Hirotake SanoHSHirotake Sano
- Hirokazu KumadaHKHirokazu Kumada
- Masao TakemuraMTMasao Takemura
- Akio NomaANAkio Noma
- Tsutomu TanakaTTTsutomu Tanaka
- Sachiro WatanabeSWSachiro Watanabe
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Metalloproteinase-mediated release of human Fas ligand.Journal of Experimental Medicine, 1995
- Evidence for a Protein Synthesis-Dependent and -Independent TNFα Cytolytic MechanismGynecologic Oncology, 1995
- Oxygen Tension Influences DNA Fragmentation and Cell Death in Glucocorticoid-Treated ThymocytesBiochemical and Biophysical Research Communications, 1995
- Reperfusion injury induces apoptosis in rabbit cardiomyocytes.Journal of Clinical Investigation, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Congenital Disorders of Cardiac Rhythm and ConductionJournal of Cardiovascular Electrophysiology, 1993
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesisThe Journal of Pathology, 1984